z-logo
open-access-imgOpen Access
Re-Profiling of US-FDA Approved Drugs for COVID-19 by In-silico Studies
Author(s) -
Akash Anandrao Parab,
Gaganjyot Kaur,
Abhishek Sharma,
Gursewak Bhuller,
Sharvari Chitnis,
Ankit Chindaliya,
Mayur Weta
Publication year - 2021
Publication title -
journal of bioinformatics and systems biology
Language(s) - English
Resource type - Journals
ISSN - 2688-5107
DOI - 10.26502/jbsb.5107021
Subject(s) - drug repositioning , in silico , drug , repurposing , medicine , pharmacology , virtual screening , approved drug , covid-19 , computational biology , drug discovery , disease , infectious disease (medical specialty) , bioinformatics , biology , gene , ecology , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here